LBO — PALI MOMI MEDICAL CENTER
IRR: 19.9% | MOIC: 2.47x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
19.9%
IRR
2.47x
MOIC
$207.1M
Entry EV
$353.8M
Exit EV
$106.6M
Equity Invested
Sources & Uses
S&UTotal · $207.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $80.4M | 38.8% | |
| Sub Debt | $20.1M | 9.7% | |
| Equity | $106.6M | 51.5% | |
| Enterprise Value | $201.1M | 97.1% | |
| Transaction Fees | $6.0M | 2.9% | |
| Total Uses | $207.1M | 100.0% |
Interpretation
INTAt 2.47x MOIC and 19.9% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $33.7M |
| Exit Ev | $353.8M |
| Net Debt At Exit | $90.2M |
| Equity At Exit | $263.6M |
| Equity Invested | $106.6M |
| Total Value Created | $157.1M |
| Value From Growth | $142.7M |
| Value From Multiple | $10.1M |
| Value From Deleveraging | $10.3M |